The Hindu Business Line : Lupin adds to Suprax basket in US

Mumbai, April 29 Lupin Ltd has launched Suprax 400 mg tablets (Cefixime USP) in the US. The product is a line extension of Lupin’s flagship anti-infective Suprax in an oral suspension form.

Suprax® 400 mg tablets will help Lupin increase its share of the $450-million antibiotic market for the treatment of urinary tract infections, a company note said. It will also extend the use of Suprax to the patient population of children over 12 years, the note added.

Lupin is also evaluating additional options of reaching out to other specialty doctors, the company said. The Suprax-brand basket now includes, Suprax (Cefixime for oral suspension 100 mg/ 5 ml and 200 mg/ 5ml) and Suprax® 400 mg tablets (Cefixime USP).

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BHEL to spend Rs 500 cr on R&D

Lupin adds to Suprax basket in US

Indoco changes financial year end

Monnet Ispat announces 25% interim

Shifts in business segments account for major growth in cos, says McKinsey

‘Reliance KG fields may go on stream by Aug’

Changes likely in depreciation norms for infrastructure projects

Srei building photovoltaic factory, power plant at Haldia

J.G. Hosiery on expansion mode

Berger Paints set to acquire Polish firm for $38.6 m

Tighten your belts, PM tells corporates

Mahindra plans ultra low-cost rural tractor

Issue of shares to foreign cos may be allowed against payment made to third party

MSD Pharma's new diabetic drug